Cabinet has approved a process to find new technology and investor partners in the Ketlaphela project, which aims to establish a government-controlled and fully integrated pharmaceutical company, focusing on the local manufacture of antiretrovirals (ARVs).
Ketlaphela is a joint venture of Pelchem Soc Ltd (Pelchem), the only fluorochemical company in the Southern Hemisphere, and the Industrial Development Corporation of South Africa Limited (IDC) the foremost development financier in South Africa.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article